A Good Mood Is a Bull's Best Friend<br />By Rev Shark<br />RealMoney.com Contributor<br />5/12/2009 9:01 AM EDT <br /><br />Pessimism leads to weakness, optimism to power. <br />-- William James<br /><br />The best thing this market has going for it is the change in mood. Although all sorts of very good negative arguments can be made, the simple fact is that market players are feeling more optimistic and are not letting this market pull back very much. <br /><br />Perhaps they are delusional or just plain wrong about how the economy is improving, but the mood is much more optimistic and stocks are acting better. Even on a negative day, plenty of stocks are still acting well, which is a major change from the dreary and pervasively negative action we saw for so long last year and until mid-March this year. <br /><br />Market players are now finding excuses to buy and keep hunting for something new each day. That action creates pockets of opportunity, so even when the major indices do pull back there is still positive action in places, which helps to keep the mood positive. <br /><br />The important thing is not to become too complacent. While we want to keep on seeking out the opportunities, we don't want to be blind to the fact that the economy still faces tremendous headwinds. For example, we are now starting to see a large number of secondary offerings, which show how huge some of the losses have been for banks and companies like Ford (F) . Offerings have the capacity to soak up a lot of liquidity, and we'll have to watch for negative repercussions. <br /><br />We are walking a tightrope right now, with some very favorable trading action in places but some tired-looking major indices that have not had even a minor correction for quite a while. As I've said often, I don't try to anticipate market turns, but we need to watch the indices closely -- the momentum there is obviously slowing. We might just churn and consolidate, but the chance of some downside is increasing. <br /><br />Some good earnings reports from smaller companies are hitting the wires, and a takeover of coal company Foundation Coal (FCL) by Alpha Natural Resources (ANR) will help the commodity group. A number of secondaries in banking and from companies like F and GMX Resources (GMXR) are a bit troubling but aren't causing much impact yet. <br /><br />We have a positive open with oil and energy stocks looking to take the early lead. Good luck and go get 'em.<br />----------------------------- <br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: AGM +59.3%, CPE +35.6%, STEC +32.3% (also upgraded to Overweight at Weisel), NNI +19.8%, CTRP +15.8%, CGA +14.5%, WINN +13.3%, NCOC +12.0%, MBI +9.2%, FLR +3.7%, DTSI +1.6%... M&A news: FCL +28.2% (Foundation Coal to be bought by ANR in all-stock deal; consideration received by FCL stockholders valued at $32.73 per share)... Select financial related names rebounding: HBAN +8.6%, AXA +4.9%, HIG +4.1%, PNC +3.0%, PRU +2.7%, CS +2.2%, C +2.1% (Citi using most of TARP capital to make loans: Report - Reuters), GS +1.3%, BAC +1.1% (Temasek, Hopu, China Fund to buy Bank of AmerIca's CCB stake - WSJ)... Select coal related names trading higher following FCL/ANR merger news: JRCC +9.4%, ACI +6.9%, MEE +5.9%, PCX +5.7%, BTU +3.2%, MRO +2.7%... Select oil/gas names seeing strength: RDS.A +2.3%, COP +1.9%, TOT +1.5%... Select drug related names trading higher premarket: AZN +3.5%, GSK +2.7%, NVS +2.4%... Other news: ABK +15.4% (up in sympathy with MBI), HUN +10.8% (announces judge ruled in favor of Huntsman on six motions), ANPI +10.6% (Angiotech Pharm and Boston Scientific welcome journal article noting important differences between drug-eluting stent brands), DRYS +4.6% (still checking)... Analyst comments: TXT +5.8% (upgraded to Overweight at JPMorgan), CHK +3.6% (upgraded to Overweight at Morgan Stanley).